Research Article | | Peer-Reviewed

Frequency and Bacterial Profile of Small Intestinal Bacterial Overgrowth in Patients with IBS D and IBS M in an Academic Hospital

Received: 7 April 2025     Accepted: 18 April 2025     Published: 19 May 2025
Views:       Downloads:
Abstract

Background: Small intestinal bacterial overgrowth (SIBO) is a condition often associated with irritable bowel syndrome (IBS), particularly IBS-D (diarrhea-predominant) and IBS-M (mixed-type). The relationship between SIBO and IBS subtypes remains poorly understood, despite its potential impact on treatment and symptom management. Methods: This observational cross-sectional study was conducted at the Department of Gastroenterology, Dhaka Medical College Hospital, from September 2018 to August 2019. A total of 104 adult patients diagnosed with IBS based on Rome IV criteria were enrolled. Duodenal aspirates were collected during upper gastrointestinal endoscopy, and SIBO was diagnosed using quantitative aerobic culture on blood agar and MacConkey agar plates, with ≥105 CFU/mL considered diagnostic. Demographic and clinical data were analyzed using SPSS software. Results: Of the 104 participants, 36.5% tested positive for SIBO. Among IBS-D patients, 53.3% were SIBO-positive, while only 13.7% of IBS-M patients showed positive results. The majority of isolates in the SIBO-positive group were Pseudomonas (78.9%), followed by E. coli (21.1%). A significant correlation was observed between SIBO and IBS-D, with higher colony counts in the SIBO-positive group. Conclusion: The study highlights a higher frequency of SIBO in IBS-D compared to IBS-M. Pseudomonas was the predominant bacterium isolated in patients with SIBO. These findings suggest the need for targeted management of SIBO in IBS-D patients.

Published in International Journal of Gastroenterology (Volume 9, Issue 1)
DOI 10.11648/j.ijg.20250901.15
Page(s) 32-36
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2025. Published by Science Publishing Group

Keywords

Small Intestinal Bacterial Overgrowth, IBS-D, IBS-M, Duodenal Aspirate, Pseudomonas, Microbiology

References
[1] Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel disorders. Gastroenterology. 2016 Feb 18: S0016-5085.
[2] Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, Koussoulas V, Barbatzas C, Pimentel M. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Digestive diseases and sciences. 2012 May; 57: 1321-9.
[3] Sachdeva S, Rawat AK, Reddy RS, Puri AS. Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: frequency and predictors. Journal of gastroenterology and hepatology. 2011 Apr; 26: 135-8.
[4] Khan A, Ding Z, Ishaq M, Bacha AS, Khan I, Hanif A, Li W, Guo X. Understanding the effects of gut microbiota dysbiosis on nonalcoholic fatty liver disease and the possible probiotics role: Recent updates. International journal of biological sciences. 2021 Feb 8; 17(3): 818.
[5] Erdogan A, Rao SS, Gulley D, Jacobs C, Lee YY, Badger C. Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test. Neurogastroenterology & Motility. 2015 Apr; 27(4): 481-9.
[6] Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut. 2007 Jun 1; 56(6): 802-8.
[7] Peppas S, Pansieri C, Piovani D, Danese S, Peyrin-Biroulet L, Tsantes AG, Brunetta E, Tsantes AE, Bonovas S. The brain-gut axis: psychological functioning and inflammatory bowel diseases. Journal of clinical medicine. 2021 Jan 20; 10(3): 377.
[8] Wu KQ, Sun WJ, Li N, Chen YQ, Wei YL, Chen DF. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance. Scandinavian journal of gastroenterology. 2019 Dec 2; 54(12): 1419-25.
[9] Rezaie A, Buresi M, Lembo A, Lin H, McCallum R, Rao S, Schmulson M, Valdovinos M, Zakko S, Pimentel M. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Official journal of the American College of Gastroenterology| ACG. 2017 May 1; 112(5): 775-84.
[10] Shah SC, Day LW, Somsouk M, Sewell JL. Meta‐analysis: antibiotic therapy for small intestinal bacterial overgrowth. Alimentary pharmacology & therapeutics. 2013 Oct; 38(8): 925-34.
[11] Ghoshal UC, Shukla R, Ghoshal U. Small intestinal bacterial overgrowth and irritable bowel syndrome: a bridge between functional organic dichotomy. Gut and liver. 2017 Mar 15; 11(2): 196.
[12] Rahman MM, Mahadeva S, Ghoshal UC. Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review. World journal of gastroenterology. 2017 Oct 7; 23(37): 6788.
[13] Hassan, Md Nazmul. A Study on Drug’s Side Effects due to Using GIT Drugs Without Prescription in Lower Class People in Bangladesh. Diss. East West University, 2017.
[14] Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study. Official journal of the American College of Gastroenterology| ACG. 2003 Feb 1; 98(2): 412-9.
[15] Ford AC, Moayyedi P, Chey WD, Harris LA, Lacy BE, Saito YA, Quigley EM. American College of Gastroenterology monograph on management of irritable bowel syndrome. Official journal of the American College of Gastroenterology ACG. 2018 Jun 1; 113: 1-8.
[16] Shah A, Talley NJ, Jones M, Kendall BJ, Koloski N, Walker MM, Morrison M, Holtmann GJ. Small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis of case-control studies. Official journal of the American College of Gastroenterology| ACG. 2020 Feb 1; 115(2): 190-201.
[17] Ghoshal U, Shukla R, Srivastava D, Ghoshal UC. Irritable bowel syndrome, particularly the constipation-predominant form, involves an increase in Methanobrevibacter smithii, which is associated with higher methane production. Gut and liver. 2016 Jul 27; 10(6): 932.
[18] Aktan I, La Ragione RM, Woodward MJ, Ando H, Abe H, Sugimoto N, Tobe T, Barnich N, Darfeuille Michaud A, Begum YA, Talukder KA. Gastrointestinal infections. Microbiology. 2007; 153: 464-73.
[19] Zhao Y, Zhu S, Dong Y, Xie T, Chai Z, Gao X, Dai Y, Wang X. The Role of Gut Microbiome in Irritable Bowel Syndrome: Implications for Clinical Therapeutics. Biomolecules. 2024 Dec 21; 14(12): 1643.
[20] Lin HC. Small intestinal bacterial overgrowth: A framework for understanding irritable bowel syndrome. JAMA. 2004; 292(7): 852-8.
[21] Rana SV, Malik A, Kaur J, et al. Small intestinal bacterial overgrowth and orocecal transit time in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2019; 31(3): e13593.
Cite This Article
  • APA Style

    Alam, M. J., Akter, M., Islam, M. S., Ahmed, F. (2025). Frequency and Bacterial Profile of Small Intestinal Bacterial Overgrowth in Patients with IBS D and IBS M in an Academic Hospital. International Journal of Gastroenterology, 9(1), 32-36. https://doi.org/10.11648/j.ijg.20250901.15

    Copy | Download

    ACS Style

    Alam, M. J.; Akter, M.; Islam, M. S.; Ahmed, F. Frequency and Bacterial Profile of Small Intestinal Bacterial Overgrowth in Patients with IBS D and IBS M in an Academic Hospital. Int. J. Gastroenterol. 2025, 9(1), 32-36. doi: 10.11648/j.ijg.20250901.15

    Copy | Download

    AMA Style

    Alam MJ, Akter M, Islam MS, Ahmed F. Frequency and Bacterial Profile of Small Intestinal Bacterial Overgrowth in Patients with IBS D and IBS M in an Academic Hospital. Int J Gastroenterol. 2025;9(1):32-36. doi: 10.11648/j.ijg.20250901.15

    Copy | Download

  • @article{10.11648/j.ijg.20250901.15,
      author = {Mohammad Jane Alam and Mahfuza Akter and Mohammad Shohidul Islam and Faruque Ahmed},
      title = {Frequency and Bacterial Profile of Small Intestinal Bacterial Overgrowth in Patients with IBS D and IBS M in an Academic Hospital
    },
      journal = {International Journal of Gastroenterology},
      volume = {9},
      number = {1},
      pages = {32-36},
      doi = {10.11648/j.ijg.20250901.15},
      url = {https://doi.org/10.11648/j.ijg.20250901.15},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijg.20250901.15},
      abstract = {Background: Small intestinal bacterial overgrowth (SIBO) is a condition often associated with irritable bowel syndrome (IBS), particularly IBS-D (diarrhea-predominant) and IBS-M (mixed-type). The relationship between SIBO and IBS subtypes remains poorly understood, despite its potential impact on treatment and symptom management. Methods: This observational cross-sectional study was conducted at the Department of Gastroenterology, Dhaka Medical College Hospital, from September 2018 to August 2019. A total of 104 adult patients diagnosed with IBS based on Rome IV criteria were enrolled. Duodenal aspirates were collected during upper gastrointestinal endoscopy, and SIBO was diagnosed using quantitative aerobic culture on blood agar and MacConkey agar plates, with ≥105 CFU/mL considered diagnostic. Demographic and clinical data were analyzed using SPSS software. Results: Of the 104 participants, 36.5% tested positive for SIBO. Among IBS-D patients, 53.3% were SIBO-positive, while only 13.7% of IBS-M patients showed positive results. The majority of isolates in the SIBO-positive group were Pseudomonas (78.9%), followed by E. coli (21.1%). A significant correlation was observed between SIBO and IBS-D, with higher colony counts in the SIBO-positive group. Conclusion: The study highlights a higher frequency of SIBO in IBS-D compared to IBS-M. Pseudomonas was the predominant bacterium isolated in patients with SIBO. These findings suggest the need for targeted management of SIBO in IBS-D patients.
    },
     year = {2025}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Frequency and Bacterial Profile of Small Intestinal Bacterial Overgrowth in Patients with IBS D and IBS M in an Academic Hospital
    
    AU  - Mohammad Jane Alam
    AU  - Mahfuza Akter
    AU  - Mohammad Shohidul Islam
    AU  - Faruque Ahmed
    Y1  - 2025/05/19
    PY  - 2025
    N1  - https://doi.org/10.11648/j.ijg.20250901.15
    DO  - 10.11648/j.ijg.20250901.15
    T2  - International Journal of Gastroenterology
    JF  - International Journal of Gastroenterology
    JO  - International Journal of Gastroenterology
    SP  - 32
    EP  - 36
    PB  - Science Publishing Group
    SN  - 2640-169X
    UR  - https://doi.org/10.11648/j.ijg.20250901.15
    AB  - Background: Small intestinal bacterial overgrowth (SIBO) is a condition often associated with irritable bowel syndrome (IBS), particularly IBS-D (diarrhea-predominant) and IBS-M (mixed-type). The relationship between SIBO and IBS subtypes remains poorly understood, despite its potential impact on treatment and symptom management. Methods: This observational cross-sectional study was conducted at the Department of Gastroenterology, Dhaka Medical College Hospital, from September 2018 to August 2019. A total of 104 adult patients diagnosed with IBS based on Rome IV criteria were enrolled. Duodenal aspirates were collected during upper gastrointestinal endoscopy, and SIBO was diagnosed using quantitative aerobic culture on blood agar and MacConkey agar plates, with ≥105 CFU/mL considered diagnostic. Demographic and clinical data were analyzed using SPSS software. Results: Of the 104 participants, 36.5% tested positive for SIBO. Among IBS-D patients, 53.3% were SIBO-positive, while only 13.7% of IBS-M patients showed positive results. The majority of isolates in the SIBO-positive group were Pseudomonas (78.9%), followed by E. coli (21.1%). A significant correlation was observed between SIBO and IBS-D, with higher colony counts in the SIBO-positive group. Conclusion: The study highlights a higher frequency of SIBO in IBS-D compared to IBS-M. Pseudomonas was the predominant bacterium isolated in patients with SIBO. These findings suggest the need for targeted management of SIBO in IBS-D patients.
    
    VL  - 9
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Sections